Package 50242-617-01

Brand: xofluza

Generic: baloxavir marboxil
NDC Package

Package Facts

Identity

Package NDC 50242-617-01
Digits Only 5024261701
Product NDC 50242-617
Product ID 50242-617_c2da90f4-a11c-46d2-be18-53d286b084cf
Description

1 PACKET in 1 CARTON (50242-617-01) / 1 GRANULE, FOR SUSPENSION in 1 PACKET

Marketing

Marketing Status
Marketed Since 2025-05-30
Brand xofluza
Generic baloxavir marboxil
Sample Package No

Linked Drug Pages (1)

Xofluza ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c2da90f4-a11c-46d2-be18-53d286b084cf", "openfda": {"unii": ["505CXM6OHG"], "rxcui": ["2100008", "2100010", "2467537", "2467539", "2536740", "2536742", "2716798", "2716800"], "spl_set_id": ["e49e1a61-1b7c-4be5-ac84-af6240b511e7"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 PACKET in 1 CARTON (50242-617-01)  / 1 GRANULE, FOR SUSPENSION in 1 PACKET", "package_ndc": "50242-617-01", "marketing_start_date": "20250530"}], "brand_name": "Xofluza", "product_id": "50242-617_c2da90f4-a11c-46d2-be18-53d286b084cf", "dosage_form": "GRANULE, FOR SUSPENSION", "pharm_class": ["Chelating Activity [MoA]", "Polymerase Acidic Endonuclease Inhibitor [EPC]", "Polymerase Acidic Endonuclease Inhibitors [MoA]"], "product_ndc": "50242-617", "generic_name": "Baloxavir Marboxil", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Xofluza", "active_ingredients": [{"name": "BALOXAVIR MARBOXIL", "strength": "40 mg/1"}], "application_number": "NDA214410", "marketing_category": "NDA", "marketing_start_date": "20250530", "listing_expiration_date": "20261231"}